Invention Application
- Patent Title: Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
-
Application No.: US13778507Application Date: 2013-02-27
-
Publication No.: US20130171098A1Publication Date: 2013-07-04
- Inventor: John A. Bender , Min Ding , Robert G. Gentles , Piyasena Hewawasam
- Applicant: Bristol-Myers Squibb Company
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K45/06
Abstract:
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
Information query
